EPISODE · May 1, 2020 · 1H 13M
#47 Sequences & Sparks: Life Sciences Innovation Mergers
from Our Curious Amalgam · host American Bar Association
Recent economic research has examined potential killer acquisitions in the U.S., and regulators here and abroad have expressed competition concerns about acquisitions of startups. But innovation is a difficult and uncertain process. This panel explores hot topics, patent thickets, biologics, and the revamped UK CMA approach in a broader discussion of the renaissance of innovation theories of harm. SESSION CHAIR / MODERATOR / SPEAKER E. Bill BATCHELOR / Skadden Arps Slate Meagher & Flom LLP, Brussels SPEAKERS Deborah FEINSTEIN / Arnold & Porter, Washington, DC W. Robert MAJURE / Cornerstone Research, Washington, DC James R. WEISS / Deputy Assistant Director, Mergers I, Federal Trade Commission, Washington, DC
NOW PLAYING
#47 Sequences & Sparks: Life Sciences Innovation Mergers
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m